Cancer-free after 12 years: Why you’re hearing the C-word more often
Two ASX-listed ventures are among the companies now investing billions of dollars to develop an...
Two ASX-listed ventures are among the companies now investing billions of dollars to develop an...
Locally-listed small cap biotech company Prescient Therapeutics hopes to shift the conversation around cancer from treatments to...
Capital dedicated by local investors to risky investments that was once largely tied up in...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.